| | Regulatory Networks in Embryo-Derived Pluripotent Stem Cells. |
 | | Pluripotent cells are first recognized in the ICM of the mouse blastocyst at embryonic day 3.5 (E3.5), and are present as late as in the pre-gastrulating embryo (Fig. |
 | | Pluripotency of ESCs can be judged by their ability to integrate, after transplantation, into the ICM of E3.5 blastocysts and, similar to the ICM, to express alkaline phosphatase, E-cadherin, stage-specific embryonic antigen-1 (SSEA1) and octamer-binding transcription factor-4 (OCT4)4 (Table 1). |
 | | When pluripotent stem cells are used instead of oocytes as recipients for nuclear transfer that is mediated by cell—cell fusion, the hybrid cells show a loss of stage- and tissue-specific markers of the somatic-cell parent (gene extinction) and a de novo activation of traits and genes which are characteristic of pluripotent cells. |
| www.euchromatin.com /Boiani01.htm (12731 words) |